Synthetic Biology Market

Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

  • Rep Id : TMRGL421
  • Published On : Apr 2014
  • No. of Pages : 143
  • Category : Pharmaceutical

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)

      2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million)

2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)

 

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Drivers

      3.2.1 Drivers

               3.2.1.1 Rising demand for improved drugs and vaccines

               3.2.1.2 Advancement in molecular biology

               3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research

               3.2.1.4 Increasing demand of genetically modified crops due to rising population

3.3 Market Restraints

      3.3.1 Ethical Issues

3.4 Market Opportunities

      3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts

3.5 Porter’s Five Force Analysis

      3.5.1 Bargaining Power of Suppliers

      3.5.2 Bargaining Power of Buyers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography

 

Chapter 4 Global Synthetic Biology Market, by Products

4.1 Introduction

      4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)

4.2 Core Products

      4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)

      4.2.2 Synthetic DNA

               4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)

      4.2.3 Synthetic Genes

               4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)

      4.2.4 Synthetic Cells

              4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)

      4.2.5 XNA (Xeno Nucleic Acid)

              4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million)

      4.2.6 Chassis Organisms

               4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)

4.3 Enabling Products

      4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)

      4.3.2 DNA Synthesis

              4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)

      4.3.3 Oligonucleotide Synthesis

              4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)

 

Chapter 5 Global Synthetic Biology Market, by Technologies

5.1 Introduction

      5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)

5.2 Genome Engineering

      5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

5.3 DNA Sequencing

      5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

5.4 Bioinformatics

      5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

5.5 Biological Components and Integrated Systems

      5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million)

 

Chapter 6 Global Synthetic Biology Market, by Applications

6.1 Introduction

      6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)

6.2 Chemicals

      6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million)

6.3 Healthcare

      6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)

6.4 Agriculture

      6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)

6.5 Others (Biosecurity, R&D, Energy and Environment)

      6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)

 

Chapter 7 Global Synthetic Biology Market, by Geography

7.1 Introduction

      7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)

7.2 North America

      7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

7.3 Europe

      7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

7.4 Asia-Pacific

      7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

7.5 Rest of the World (RoW)

      7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

 

Chapter 8 Competitive Landscape

8.1 Heat Map Analysis for Key Market Players

      8.1.1 Amyris, Inc.

      8.1.2 DuPont, Inc.

      8.1.3 Royal DSM

      8.1.4 Evolva Holding

      8.1.5 Life Technologies Corporation

8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013

 

Chapter 9 Recommendations

9.1 Market Strategy for Success

      9.1.1 Focus on investing in research and development activities

      9.1.2 Strategic alliance, mergers and acquisitions

9.2 Barriers to be Considered

      9.2.1 Ethical issues associated with synthetic biology products

 

Chapter 10 Company Profiles

10.1 Agrivida, Inc.

       10.1.1 Company Overview

       10.1.2 Financial Overview

       10.1.3 Product Portfolio

       10.1.4 Business Strategies

       10.1.5 Recent Developments

10.2 Amyris, Inc.

       10.2.1 Company Profile

       10.2.2 Financial Overview

       10.2.3 Product Portfolio

       10.2.4 Business Strategies

       10.2.5 Recent Developments

10.3 Algenol Biofuels, Inc.

       10.3.1 Company Overview

       10.3.2 Financial Overview

       10.3.3 Product Portfolio

       10.3.4 Business Strategies

       10.3.5 Recent Developments

10.4 ATG:biosynthetics GmbH

       10.4.1 Company Overview

       10.4.2 Financial Overview

       10.4.3 Product Portfolio

       10.4.4 Business Strategies

       10.4.5 Recent Developments

10.5 Bayer AG

       10.5.1 Company Overview

       10.5.2 Financial Overview

       10.5.3 Product Portfolio

       10.5.4 Business Strategies

       10.5.5 Recent Developments

10.6 Bristol-Myers Squibb

       10.6.1 Company Overview

       10.6.2 Financial Overview

       10.6.3 Product Portfolio

       10.6.4 Business Strategies

       10.6.5 Recent Developments

10.7 BIONEER CORPORATION

       10.7.1 Company Overview

       10.7.2 Product Portfolio

       10.7.3 Business Strategies

       10.7.4 Recent Developments

10.8 Biosearch Technologies, Inc.

       10.8.1 Company Overview

       10.8.2 Financial Overview

       10.8.3 Product Portfolio

       10.8.4 Business Strategies

       10.8.5 Recent Developments

10.9 CBC Comprehensive Biomarker Center GmbH

       10.9.1 Company Overview

       10.9.2 Financial Overview

       10.9.3 Product Portfolio

       10.9.4 Business Strategies

       10.9.5 Recent Developments

10.10 Cobalt Technologies

       10.10.1 Company Overview

       10.10.2 Financial Overview

       10.10.3 Product Portfolio

       10.10.4 Business Strategies

       10.10.5 Recent Developments

10.11 DuPont, Inc.

       10.11.1 Company Overview

       10.11.2 Financial Overview

       10.11.3 Product Portfolio

       10.11.4 Business Strategies

       10.11.5 Recent Developments

10.12 Evolva SA

       10.12.1 Company Overview

       10.12.2 Financial Overview

       10.12.3 Product Portfolio

       10.12.4 Business Strategies

       10.12.5 Recent Developments

10.13 Exxon Mobil Corporation

       10.13.1 Company Overview

       10.13.2 Financial Overview

       10.13.3 Product Portfolio

       10.13.4 Business Strategies

       10.13.5 Recent Developments

10.14 Ginkgo Bioworks

       10.14.1 Company Overview

       10.14.2 Financial Overview

       10.14.3 Product Portfolio

       10.14.4 Business Strategies

       10.14.5 Recent Developments

10.15 GeneWorks Pty Ltd.

       10.15.1 Company Overview

       10.15.2 Financial Overview

       10.15.3 Product Portfolio

       10.15.4 Business Strategies

       10.15.5 Recent Developments

10.16 Genomatica, Inc.

       10.16.1 Company Overview

       10.16.2 Financial Overview

       10.16.3 Product Portfolio

       10.16.4 Business Strategies

       10.16.5 Recent Developments

10.17 GeneScript Corporation

       10.17.1 Company Overview

       10.17.2 Financial Overview

       10.17.3 Product Portfolio

       10.17.4 Business Strategies

       10.17.5 Recent Developments

10.18 Gevo, Inc.

       10.18.1 Company Overview

       10.18.2 Financial Overview

       10.18.3 Product Portfolio

       10.18.4 Business Strategies

       10.18.5 Recent Developments

10.19 Green Biologics Limited

       10.19.1 Company Overview

       10.19.2 Financial Overview

       10.19.3 Product Portfolio

       10.19.4 Business Strategies

       10.19.5 Recent Developments

10.20 New England Biolabs, Inc.

       10.20.1 Company Overview

       10.20.2 Financial Overview

       10.20.3 Product Portfolio

       10.20.4 Business Strategies

       10.20.5 Recent Developments

10.21 OriGene Technologies, Inc.

       10.21.1 Company Overview

       10.21.2 Financial Overview

       10.21.3 Product Portfolio

       10.21.4 Business Strategies

       10.21.5 Recent Developments

10.22 REG Life Sciences, LLC

       10.22.1 Company Overview

       10.22.2 Financial Overview

       10.22.3 Product Portfolio

       10.22.4 Business Strategies

       10.22.5 Recent Developments

10.23 Royal DSM

       10.23.1 Company Overview

       10.23.2 Financial Overview

       10.23.3 Product Portfolio

       10.23.4 Business Strategies

       10.23.5 Recent Developments

10.24 Thermo Fisher Scientific, Inc.

       10.24.1 Company Overview

       10.24.2 Financial Overview

       10.24.3 Product Portfolio

       10.24.4 Business Strategies

       10.24.5 Recent Developments

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)

TABLE 3 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)

TABLE 4 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)

TABLE 5 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)

TABLE 6 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)

TABLE 7 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)

TABLE 8 U.S. Bio-fuels Pipeline Products, by Organizations

TABLE 9 Developed Drugs and Vaccines Utilizing the Concept of Synthetic Biology

TABLE 10 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)

TABLE 11 List of Organizations and their Synthetic Biology Products and Applications

List of Figures

 

FIG. 1 Synthetic Biology Market Segmentation

FIG. 2 Global Synthetic Biology Market, by Technologies, 2012 (USD Million)

FIG. 3 Comparative Analysis: Global Synthetic Biology Market, by Geography, 2012 and 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Synthetic Biology Market

FIG. 5 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography

FIG. 6 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)

FIG. 7 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)

FIG. 8 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)

FIG. 9 Global XNA Market Revenue, 2014 – 2019 (USD Million)

FIG. 10 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)

FIG. 11 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)

FIG. 12 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)

FIG. 13 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 14 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 15 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 16 Global Biological Components and Integrated Systems in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 17 Global Synthetic Biology in Chemicals Market Revenue, 2011 – 2019 (USD Million)

FIG. 18 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)

FIG. 19 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)

FIG. 20 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)

FIG. 21 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 22 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 23 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 24 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)

FIG. 25 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013

FIG. 26 Amyris, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 27 Bayer AG: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 28 Bristol-Myers Squibb: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 29 DuPont, Inc.: Annual Revenue, 2010– 2012 (USD Million)

FIG. 30 Evolva SA: Annual Sales, 2010 – 2012 (USD Million), 1 CHF = 1.13 USD

FIG. 31 Exxon Mobil Corporation: Annual Sales, 2010 – 2012 (USD Billion)

FIG. 32 Gevo, Inc.: Annual Sales, 2010 – 2012 (USD Million)

FIG. 33 Renewable Energy Group, Inc.: Annual Sales, 2011 – 2013 (USD Million)

FIG. 34 Royal DSM: Annual Revenue, 2010– 2012 (USD Million)

FIG. 35 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million)